Skip to content
SmartFigure
SBI Mutual Fund

SBI Healthcare Opportunities Fund

SBI Mutual Fund · Direct plan · Growth

3-year returns
24.3%
a year
NAV
₹606.67
▲ 0.91% · 18 Sept 2026
Fund size
₹5,796 Cr
Expense ratio
1.02%
a year
Minimum SIP
₹500

Figures are for the Direct plan. The Regular plan, bought through a distributor, is at ₹523.62 and has returned 23.03% a year over 3 years.

Returns, and where it stands

Against the average sectoral / thematic fund, and its place among them. Anything longer than a year is a yearly rate.

PeriodThis fundCategoryRank
1 year20.9%5.2%ahead12 of 221
3 years24.3%14.5%ahead4 of 136
5 years18.5%12.9%ahead16 of 98
10 years14.8%14.5%ahead35 of 68
Every period, and the Regular plan →
PeriodDirectRegular
1 month0.6%0.5%
3 months10.9%10.6%
6 months25.2%24.6%
1 year20.9%19.7%
2 yearsp.a.13.4%12.2%
3 yearsp.a.24.3%23%
5 yearsp.a.18.5%17.3%
7 yearsp.a.26%24.7%
10 yearsp.a.14.8%13.6%

Figures are for the Direct plan, and the rank compares it against the same plan of its peers, best first. Based on NAV history from Sept 2016.

Plan

NAV history

▲ 20.88% in the last 1Y

464.8536.8608.818 Sept 202519 Mar 202618 Sept 2026

Hover or tap the chart for the NAV on any date. Past NAVs are adjusted for unit splits.

If you had invested in this fund

Investment type
years
Total invested
₹1,80,000
Gain
₹66,268
XIRR (per year)
21.52%
Value today
₹2,46,268

36 monthly instalments from 22 Sept 2023, valued at the latest NAV. Past returns do not guarantee future returns.

What this fund holds

As on 31 August 2026

  • Equity96.8%
  • Cash3.16%

Top holdings

The ten largest holdings and their share of the fund
Sun Pharmaceutical Industries LtdPharmaceuticals & Biotechnology12.3%
Divi's Laboratories LtdPharmaceuticals & Biotechnology8.17%
Apollo Hospitals Enterprise LtdHealthcare Services4.91%
Acutaas Chemicals LtdPharmaceuticals & Biotechnology4.91%
Torrent Pharmaceuticals LtdPharmaceuticals & Biotechnology4.72%
Cipla LtdPharmaceuticals & Biotechnology4.67%
Max Healthcare Institute LtdHealthcare Services4.31%
Laurus Labs LtdPharmaceuticals & Biotechnology3.96%
Aurobindo Pharma LtdPharmaceuticals & Biotechnology3.9%
Aster DM Quality Care LtdHealthcare Services3.52%

and 23 more holdings.

Where the equity sits

  • Pharmaceuticals & Biotechnology62%
  • Healthcare Services27.6%
  • Chemicals & Petrochemicals5.17%
  • Healthcare Equipment & Supplies1.94%

From the monthly portfolio SBI Mutual Fund publishes for this scheme, as required by SEBI. Cash covers bank balances, treasury bills lent overnight and money due to the scheme, which carry no ISIN and so are shown as the remainder.Original disclosure

What the ride has been like

Worked out from this fund's own NAV history, not a rating.

How bumpy
12.9% a year
2.8% less than the category average — the steadier side
Worst fall so far
−28.1%
Sept 2016 to Mar 2020, against −25.3% for the category.
Years that made money
70%
Of every one-year stretch it has been through.
Over any three years
-8.9% to 31.1%
A year, at worst and at best. Typically 19.7%.

Fund details

Minimum lumpsum
₹5,000
Minimum top-up
₹1,000
Lock-in
None
Plan started
1 Jan 2013
Portfolio turnover
0.35x
Expense ratio
1.02%
as of 31 Jul 2026

Managed by Tanmaya Desai

Direct plan figures, last checked on 20 Sept 2026. Exit load and the scheme's benchmark are in thescheme document.

How it compares

SBI Healthcare Opportunities Fund against other funds in the Sectoral / Thematic Fund category
Fund1Y3Y5YExpenseFund size
Nippon India Taiwan Equity Fund118%61.43%1.24%₹1,128 Cr
HDFC Defence Fund21.09%37.07%0.9%₹11,478 Cr
HDFC Transportation and Logistics Fund7.35%24.8%1.09%₹2,116 Cr
SBI Healthcare Opportunities Fund20.88%24.31%18.52%1.02%₹5,796 Cr
UTI - Healthcare Fund16.82%24.15%16.09%1.28%₹1,444 Cr
LIC MF Infrastructure Fund8.97%23.9%21.88%1.35%₹1,174 Cr
Franklin Asian Equity Fund34.46%23.1%9.67%1.6%₹996 Cr

About SBI Healthcare Opportunities Fund

SBI Healthcare Opportunities Fund is a sectoral / thematic fund managed by SBI Mutual Fund. Invest in one sector (such as banking, IT or pharma) or a theme (such as consumption or infrastructure). Concentrated and higher risk; suited to investors with a view on that sector.

To provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.

The scheme's stated objective, as published by SBI Mutual Fund.

The NAV (net asset value) is the price of one unit of the fund. It is published by the fund house every business day and changes with the value of the fund's holdings. The Growth option reinvests all gains, so its NAV reflects the fund's total return.

Tax on your gains

Gains are taxed as equity: sell within 12 months and the gain is short-term, taxed at 20%. Hold longer and it is long-term, taxed at 12.5% on gains above ₹1.25 lakh in a financial year, across all your equity investments.

Work out what you would owe with the capital gains tax calculator.

Every plan and option, with scheme codes
PlanOptionNAVScheme code
DirectGrowth₹606.6711119783
DirectIDCW₹421.497119782
RegularGrowth₹523.6243102823
RegularIDCW₹329.8558100644

Frequently asked questions

What is the NAV of SBI Healthcare Opportunities Fund today?

The NAV of SBI Healthcare Opportunities Fund (Direct plan, Growth) is ₹606.6711 and the Regular plan NAV is ₹523.6243, as of 18 Sept 2026.

What returns has SBI Healthcare Opportunities Fund given?

Over the last year the Direct plan returned 20.88%, and 24.31% a year over 3 years and 18.52% a year over 5 years. That places it 4 of 136 funds in its category over 3 years. Past returns do not guarantee future returns.

What is the expense ratio of SBI Healthcare Opportunities Fund?

The Direct plan charges 1.02% a year, as disclosed on 31 Jul 2026. The fee is already taken out of the NAV, so the returns above are what you keep.

What is the minimum SIP amount in SBI Healthcare Opportunities Fund?

You can start a monthly SIP with ₹500, or invest a lump sum of ₹5,000 or more.

How much has SBI Healthcare Opportunities Fund fallen in the past?

Its deepest fall was 28.1% from 22 Sept 2016 to 23 Mar 2020. Of every one-year stretch in its history, 70% ended in a gain.

What does SBI Healthcare Opportunities Fund invest in?

As on 31 Aug 2026 it held 33 positions, the largest being Sun Pharmaceutical Industries Ltd (12.3%), Divi's Laboratories Ltd (8.2%), Apollo Hospitals Enterprise Ltd (4.9%). Its biggest sector was pharmaceuticals & biotechnology at 62% of the fund. Portfolios change every month.

Which category does SBI Healthcare Opportunities Fund belong to?

It is a Sectoral / Thematic Fund from SBI Mutual Fund. Invest in one sector (such as banking, IT or pharma) or a theme (such as consumption or infrastructure). Concentrated and higher risk; suited to investors with a view on that sector.

What is the difference between the Direct and Regular plan?

Both invest in the same portfolio. The Direct plan is bought straight from the fund house or a direct platform and has a lower expense ratio because no distributor commission is paid, so its NAV grows slightly faster over time.

How are gains from SBI Healthcare Opportunities Fund taxed?

Gains are taxed as equity: sell within 12 months and the gain is short-term, taxed at 20%. Hold longer and it is long-term, taxed at 12.5% on gains above ₹1.25 lakh in a financial year, across all your equity investments.

Source: NAVs published by the fund house through AMFI. Mutual fund investments are subject to market risks; read all scheme-related documents carefully. Past performance does not guarantee future returns. This page is for information only and is not a recommendation to buy or sell.